- ICH GCP
- EU: s kliniska prövningsregister
Senaste försöken
EudraCT Number: 2004-002143-27 | Sponsor Protocol Number: 1208.15 | Start Date: 2005-02-15 | ||||||
Sponsor Name: Boehringer Ingelheim Austria GmbH | ||||||||
Full Title: A double-blind, stratified, randomised, parallel, placebo-controlled, multi-centre study to compare the efficacy and safety of duloxetine hydrochloride (40mg twice a day) and tolterodine tartrate (... | ||||||||
Medical condition: Urge Urinary Incontinence (UUI) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||
Trial protocol: AT (Completed) DK (Prematurely Ended) SE (Completed) DE (Completed) | ||||||||
Trial results: View results |